These findings suggest that SOX17, through its activation of the wnt/beta-catenin pathway in endometrial cancer cells, contributes to malignant biological activities like proliferation, invasion, and migration, and also markedly augments angiogenesis. The gene discussed is SOX17; the disease is endometrial cancer.